Myriad Genetics Cash on Hand 2006-2019 | MYGN

Myriad Genetics cash on hand from 2006 to 2019. Cash on hand can be defined as cash deposits at financial institutions that can immediately be withdrawn at any time, and investments maturing in one year or less that are highly liquid and therefore regarded as cash equivalents and reported with or near cash line items.
Myriad Genetics Annual Cash on Hand
(Millions of US $)
2018 $181
2017 $151
2016 $159
2015 $145
2014 $186
2013 $372
2012 $341
2011 $346
2010 $403
2009 $317
2008 $329
2007 $214
2006 $228
2005 $114
Myriad Genetics Quarterly Cash on Hand
(Millions of US $)
Q3 2019 $150
Q2 2018 $165
Q1 2018 $168
Q4 2018 $181
Q3 2018 $157
Q2 2017 $144
Q1 2017 $148
Q4 2017 $151
Q3 2017 $172
Q2 2016 $163
Q1 2016 $148
Q4 2016 $159
Q3 2016 $217
Q2 2015 $219
Q1 2015 $155
Q4 2015 $145
Q3 2015 $134
Q2 2014 $187
Q1 2014 $182
Q4 2014 $186
Q3 2014 $212
Q2 2013 $354
Q1 2013 $357
Q4 2013 $372
Q3 2013 $336
Q2 2012 $359
Q1 2012 $349
Q4 2012 $341
Q3 2012 $337
Q2 2011 $351
Q1 2011 $350
Q4 2011 $346
Q3 2011 $361
Q2 2010 $391
Q1 2010 $428
Q4 2010 $403
Q3 2010 $399
Q2 2009 $345
Q1 2009 $358
Q4 2009 $317
Q3 2009 $402
Q2 2008 $332
Q1 2008 $308
Q4 2008 $329
Q3 2008 $204
Q2 2007 $181
Q1 2007 $189
Q4 2007 $214
Q3 2007 $304
Q2 2006 $204
Q1 2006 $212
Q4 2006 $228
Q3 2006 $229
Q2 2005 $235
Q1 2005 $103
Q4 2005 $114
Q3 2005 $78
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $1.663B $0.773B
Myriad Genetics, Inc. is focused on revolutionizing patient care through the discovery, development and marketing of transformative molecular diagnostic tests that address pressing clinical needs across multiple medical specialties. Myriad is the pioneer and leader in molecular diagnostics, offering innovative products that transform patients' lives. These products include leading molecular diagnostic tests for hereditary cancer, urological cancer, lung cancer, autoimmune disorders and other diseases. Myriad has invested heavily in educating patients and healthcare professionals about the role genes and proteins play in disease. Myriad's hereditary cancer genetic testing, which helps healthcare professionals better manage and tailor medical care. Myriad is expanding their reach and increasing their impact on patient care by introducing new molecular diagnostic and companion diagnostic tests for a growing number of diseases.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $112.497B 12.72
Gilead Sciences (GILD) United States $87.305B 10.60
Celgene (CELG) United States $65.723B 11.13
Illumina (ILMN) United States $52.638B 61.00
Biogen (BIIB) United States $46.591B 8.84
Vertex Pharmaceuticals (VRTX) United States $46.140B 55.77
Regeneron Pharmaceuticals (REGN) United States $34.192B 16.07
Alexion Pharmaceuticals (ALXN) United States $28.063B 15.88
Incyte (INCY) United States $18.787B 76.18
BioMarin Pharmaceutical (BMRN) United States $15.010B 0.00
Exact Sciences (EXAS) United States $14.393B 0.00
Seattle Genetics (SGEN) United States $11.136B 0.00
Array BioPharma (ARRY) United States $10.247B 0.00
Sarepta Therapeutics (SRPT) United States $9.207B 0.00
QIAGEN (QGEN) Netherlands $9.104B 29.90
Bio-Techne Corp (TECH) United States $7.705B 52.57
Alnylam Pharmaceuticals (ALNY) United States $7.579B 0.00
Guardant Health (GH) United States $7.547B 0.00
Bluebird Bio (BLUE) United States $6.610B 0.00
Galapagos (GLPG) Belgium $6.470B 0.00
Exelixis (EXEL) United States $6.379B 16.26
Amarin (AMRN) Ireland $6.009B 0.00
BeiGene (BGNE) Cayman Islands $5.645B 0.00
Ascendis Pharma (ASND) Denmark $5.084B 0.00
Moderna (MRNA) United States $4.530B 0.00
ARGENX SE-ADR (ARGX) Netherlands $4.480B 0.00
Blueprint Medicines (BPMC) United States $4.479B 0.00
Spark Therapeutics (ONCE) United States $3.872B 0.00
Repligen (RGEN) United States $3.800B 94.67
ACADIA Pharmaceuticals (ACAD) United States $3.717B 0.00
China Biologic Products (CBPO) China $3.705B 23.53
Mirati Therapeutics (MRTX) United States $3.682B 0.00
Global Blood Therapeutics (GBT) United States $3.521B 0.00
Ultragenyx Pharmaceutical (RARE) United States $3.421B 0.00
Alkermes (ALKS) Ireland $3.417B 0.00
Allogene Therapeutics (ALLO) United States $3.181B 0.00
MorphoSys AG Unsponsored ADR (MOR) Germany $3.129B 0.00
UniQure (QURE) Netherlands $2.835B 0.00
Amicus Therapeutics (FOLD) United States $2.779B 0.00
Arena Pharmaceuticals (ARNA) United States $2.776B 5.64
Lion Biotechnologies (IOVA) United States $2.686B 0.00
Reata Pharmaceuticals (RETA) United States $2.552B 0.00
Medicines (MDCO) United States $2.495B 0.00
Immunomedics (IMMU) United States $2.490B 0.00
Emergent Biosolutions (EBS) United States $2.421B 21.03
Halozyme Therapeutics (HALO) United States $2.369B 0.00
Intercept Pharmaceuticals (ICPT) United States $2.334B 0.00
CRISPR Therapeutics AG (CRSP) Switzerland $2.327B 0.00
NeoGenomics (NEO) United States $2.156B 141.13
Ligand Pharmaceuticals (LGND) United States $2.154B 17.84
Akcea Therapeutics (AKCA) United States $2.152B 0.00
MyoKardia (MYOK) United States $2.110B 0.00
Acceleron Pharma (XLRN) United States $2.086B 0.00
Zai Lab Unsponsored ADR (ZLAB) China $2.016B 0.00
Genomic Health (GHDX) United States $2.004B 42.57
Insmed (INSM) United States $1.987B 0.00
Denali Therapeutics (DNLI) United States $1.929B 0.00
REGENXBIO (RGNX) United States $1.842B 0.00
Biohaven Pharmaceutical Holding (BHVN) United States $1.772B 0.00
Allakos (ALLK) United States $1.743B 0.00
Audentes Therapeutics (BOLD) United States $1.656B 0.00
Cambrex (CBM) United States $1.511B 19.11
Apellis Pharmaceuticals (APLS) United States $1.506B 0.00
AnaptysBio (ANAB) United States $1.484B 0.00
Nabriva Therapeutics AG (NBRV) Ireland $1.471B 0.00
Coherus BioSciences (CHRS) United States $1.466B 0.00
Gossamer Bio (GOSS) United States $1.458B 0.00
Innoviva (INVA) United States $1.417B 3.92
Fate Therapeutics (FATE) United States $1.285B 0.00
Alector (ALEC) United States $1.227B 0.00
Aimmune Therapeutics (AIMT) United States $1.222B 0.00
Athenex (ATNX) United States $1.207B 0.00
Epizyme (EPZM) United States $1.207B 0.00
Momenta Pharmaceuticals (MNTA) United States $1.192B 0.00
Rubius Therapeutics (RUBY) United States $1.167B 0.00
RA PHARMCTL INC (RARX) United States $1.153B 0.00
Orchard Therapeutics Sponsored ADR (ORTX) United Kingdom $1.147B 0.00
Editas Medicine (EDIT) United States $1.124B 0.00
Sangamo Therapeutics (SGMO) United States $1.122B 0.00
Dicerna Pharmaceuticals (DRNA) United States $1.080B 0.00
G1 THERAPEUTICS (GTHX) United States $1.034B 0.00
CORTEXYME INC (CRTX) United States $1.021B 0.00
Codexis (CDXS) United States $1.005B 0.00
Twist Bioscience (TWST) United States $0.954B 0.00
NGM Biopharmaceuticals (NGM) United States $0.952B 0.00
ANI Pharmaceuticals (ANIP) United States $0.939B 16.65
Eidos Therapeutics (EIDX) United States $0.932B 0.00
Atara Biotherapeutics (ATRA) United States $0.926B 0.00
Alder BioPharmaceuticals (ALDR) United States $0.922B 0.00
ZIOPHARM Oncology Inc (ZIOP) United States $0.908B 0.00
Deciphera Pharmaceuticals (DCPH) United States $0.905B 0.00
WAVE Life Sciences (WVE) Singapore $0.887B 0.00
Zymeworks (ZYME) Canada $0.875B 0.00
Retrophin (RTRX) United States $0.830B 0.00
Principia Biopharma (PRNB) United States $0.815B 0.00
Axsome Therapeutics (AXSM) United States $0.799B 0.00
Cara Therapeutics (CARA) United States $0.784B 0.00
Inotek Pharmaceuticals (RCKT) United States $0.776B 0.00
Kiniksa Pharmaceuticals (KNSA) Bermuda $0.775B 0.00
Vericel (VCEL) United States $0.773B 0.00
Y-mAbs Therapeutics (YMAB) United States $0.769B 0.00
MeiraGTx Holdings (MGTX) United States $0.766B 0.00
GENFIT Unsponsored ADR (GNFT) France $0.755B 0.00
Kura Oncology (KURA) United States $0.747B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.741B 35.00
Rhythm Pharmaceuticals (RYTM) United States $0.737B 0.00
Arvinas (ARVN) United States $0.726B 0.00
Intra-Cellular Therapies (ITCI) United States $0.719B 0.00
Clovis Oncology (CLVS) United States $0.711B 0.00
Adverum Biotechnologies (ADVM) United States $0.702B 0.00
Intellia Therapeutics (NTLA) United States $0.681B 0.00
Precision BioSciences (DTIL) United States $0.665B 0.00
Myovant Sciences (MYOV) United Kingdom $0.658B 0.00
Zealand Pharma (ZEAL) Denmark $0.648B 7.57
Stemline Therapeutics (STML) United States $0.647B 0.00
Autolus Therapeutics Sponsored ADR (AUTL) United Kingdom $0.638B 0.00
Heska (HSKA) United States $0.636B 65.14
Cytokineticsorporated (CYTK) United States $0.626B 0.00
Cellectis (CLLS) France $0.618B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.611B 0.00
Krystal Biotech (KRYS) United States $0.582B 0.00
Viking Therapeutics (VKTX) United States $0.578B 0.00
Anika Therapeutics (ANIK) United States $0.549B 18.74
Milestone Pharmaceuticals (MIST) Canada $0.545B 0.00
Revance Therapeutics (RVNC) United States $0.535B 0.00
Mesoblast (MESO) Australia $0.527B 0.00
ObsEva SA (OBSV) Switzerland $0.525B 0.00
Magenta Therapeutics (MGTA) United States $0.498B 0.00
Puma Biotechnology (PBYI) United States $0.493B 0.00
DBV Technologies (DBVT) France $0.492B 0.00
CytomX Therapeutics (CTMX) United States $0.479B 0.00
BeyondSpring (BYSI) United States $0.466B 0.00
Provention Bio (PRVB) United States $0.454B 0.00
Replimune (REPL) United States $0.453B 0.00
UROGEN PHARMA (URGN) United States $0.452B 0.00
Sorrento Therapeutics (SRNE) United States $0.436B 0.00
Arcus Biosciences (RCUS) United States $0.422B 0.00
Kodiak Sciences (KOD) United States $0.421B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $0.417B 0.00
Agenus (AGEN) United States $0.408B 0.00
MediciNova (MNOV) United States $0.405B 0.00
Synthorx (THOR) United States $0.403B 0.00
Prothena (PRTA) Ireland $0.393B 0.00
Scholar Rock Holding (SRRK) United States $0.392B 0.00
BioDelivery Sciences (BDSI) United States $0.389B 0.00
Achillion Pharmaceuticals (ACHN) United States $0.377B 0.00
Kaleido Biosciences (KLDO) $0.377B 0.00
AVROBIO (AVRO) United States $0.375B 0.00
Albireo Pharma (ALBO) United States $0.374B 0.00
UNITY Biotechnology (UBX) $0.373B 0.00
Sinovac Biotech (SVA) China $0.371B 0.00
Biofrontera AG Sponsored ADR (BFRA) Germany $0.369B 0.00
PDL BioPharma (PDLI) United States $0.369B 8.80
ProQR Therapeutics (PRQR) Netherlands $0.363B 0.00
ResTORbio (TORC) United States $0.357B 0.00
AC Immune SA (ACIU) Switzerland $0.355B 22.87
Stealth BioTherapeutics Sponsored ADR (MITO) United States $0.355B 0.00
Gritstone Oncology (GRTS) United States $0.351B 0.00
Senesco Technologies (ELOX) United States $0.345B 0.00
Acorda Therapeutics (ACOR) United States $0.340B 5.98
NuCana Sponsored ADR (NCNA) United Kingdom $0.339B 0.00
Kindred Biosciences (KIN) United States $0.333B 0.00
Syros Pharmaceuticals (SYRS) United States $0.319B 0.00
Merus (MRUS) Netherlands $0.316B 0.00
NEXTCURE INC (NXTC) United States $0.315B 0.00
Cyclerion Therapeutics (CYCN) United States $0.308B 0.00
PHASEBIO PHARMA (PHAS) United States $0.304B 0.00
AMAG Pharmaceuticals (AMAG) United States $0.300B 0.00
Evelo Biosciences (EVLO) United States $0.278B 0.00
Geron (GERN) United States $0.272B 0.00
XBiotech (XBIT) United States $0.271B 0.00
Protagonist Therapeutics (PTGX) United States $0.270B 0.00
Sutro Biopharma (STRO) United States $0.268B 0.00
LogicBio Therapeutics (LOGC) United States $0.267B 0.00
Cellular Biomedicine (CBMG) United States $0.263B 0.00
Athersys (ATHX) United States $0.259B 0.00
Inovio Pharmaceuticals (INO) United States $0.247B 0.00
Xenon Pharmaceuticals (XENE) Canada $0.246B 0.00
Urovant Sciences (UROV) United States $0.242B 0.00
Cel-Sci (CVM) United States $0.242B 0.00
Chiasma (CHMA) United States $0.242B 0.00
Dynavax Technologies (DVAX) United States $0.237B 0.00
Palatin Technologies (PTN) United States $0.237B 0.00
Spero Therapeutics (SPRO) United States $0.237B 0.00
Constellation Pharmaceuticals (CNST) United States $0.233B 0.00
Syndax Pharmaceuticals (SNDX) United States $0.229B 0.00
Abeona Therapeutics (ABEO) United States $0.227B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.226B 0.00
Synlogic (SYBX) United States $0.226B 0.00
Five Prime Therapeutics (FPRX) United States $0.220B 0.00
Kamada (KMDA) Israel $0.218B 8.45
Avid Bioservices (CDMO) United States $0.217B 0.00
Kadmon Holdings (KDMN) United States $0.214B 0.00
Neothetics (EVFM) United States $0.213B 0.00
AXCELLA HEALTH (AXLA) United States $0.212B 0.00
MannKind (MNKD) United States $0.210B 0.00
ChromaDex (CDXC) United States $0.210B 0.00
ADMA Biologics Inc (ADMA) United States $0.209B 0.00
Cerecor (CERC) United States $0.209B 0.00
Celcuity (CELC) United States $0.207B 0.00
Eiger BioPharmaceuticals (EIGR) United States $0.206B 0.00
Mersana Therapeutics (MRSN) United States $0.204B 0.00
Compugen (CGEN) Israel $0.201B 0.00
Pfenex (PFNX) United States $0.195B 0.00
Kala Pharmaceuticals (KALA) United States $0.194B 0.00
IDEAYA BIOSCI (IDYA) United States $0.192B 0.00
Enochian BioSciences (ENOB) United States $0.190B 0.00
BICYCLE THERAPT (BCYC) United Kingdom $0.188B 0.00
CorMedix Inc (CRMD) United States $0.184B 0.00
Aeglea BioTherapeutics (AGLE) United States $0.182B 0.00
Arsanis (XFOR) United States $0.182B 0.00
Enzo Biochem (ENZ) United States $0.177B 0.00
OSMOTICA PHARM (OSMT) United States $0.176B 0.00
Solid Biosciences (SLDB) United States $0.171B 0.00
Strongbridge Biopharma (SBBP) United States $0.171B 9.84
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.168B 0.00
Affimed (AFMD) Germany $0.167B 0.00
Anavex Life Sciences (AVXL) United States $0.166B 0.00
Cue Biopharma (CUE) United States $0.165B 0.00
BioXcel Therapeutics (BTAI) United States $0.164B 0.00
BioTime (BTX) United States $0.159B 10.60
OvaScience (MLND) United States $0.157B 0.00
Liquidia Technologies (LQDA) United States $0.156B 0.00
Dyadic (DYAI) United States $0.156B 0.00
TOCAGEN INC (TOCA) United States $0.151B 0.00
Kezar Life Sciences (KZR) United States $0.146B 0.00
Axovant Sciences (AXGT) United States $0.146B 0.00
Menlo Therapeutics (MNLO) United States $0.144B 0.00
APPLIED THERAPT (APLT) United States $0.143B 0.00
Aduro Biotech (ADRO) United States $0.143B 0.00
TREVI THERAPTCS (TRVI) United States $0.141B 0.00
Intec Pharma (NTEC) Israel $0.139B 0.00
XOMA (XOMA) United States $0.139B 0.00
HOOKIPA PHARMA (HOOK) United States $0.138B 0.00
Mustang Bio (MBIO) United States $0.138B 0.00
Arbutus Biopharma (ABUS) Canada $0.138B 0.00
Novavax (NVAX) United States $0.132B 0.00
Alcobra (ARCT) United States $0.128B 0.00
Checkpoint Therapeutics (CKPT) United States $0.128B 0.00
Eton Pharmaceuticals (ETON) United States $0.128B 0.00
Verastem (VSTM) United States $0.127B 0.00
Aptose Biosciences (APTO) Canada $0.125B 0.00
Paratek Pharmaceuticals (PRTK) United States $0.122B 0.00
Gamida Cell (GMDA) Israel $0.121B 0.00
VolitionRX (VNRX) Singapore $0.119B 0.00
Erytech Pharma SA Sponsored ADR (ERYP) France $0.119B 0.00
SESEN BIO, INC (SESN) United States $0.116B 0.00
Celyad SA (CYAD) Belgium $0.116B 0.00
Seres Therapeutics (MCRB) United States $0.115B 0.00
AVEO Pharmaceuticals (AVEO) United States $0.114B 0.00
Nymox Pharmaceutical (NYMX) Canada $0.114B 0.00
ASLAN Pharmaceuticals (ASLN) Singapore $0.111B 0.00
VBI Vaccines (VBIV) United States $0.109B 0.00
Aptinyx (APTX) United States $0.109B 0.00
Tiziana Life Sciences Sponsored ADR (TLSA) United Kingdom $0.109B 0.00
NantKwest (NK) United States $0.109B 0.00
Fortress Biotech (FBIO) United States $0.108B 0.00
Equillium (EQ) United States $0.103B 0.00
Corvus Pharmaceuticals (CRVS) United States $0.100B 0.00
Allena Pharmaceuticals (ALNA) United States $0.093B 0.00
INmune Bio (INMB) United States $0.091B 0.00
Catalyst Biosciences (CBIO) United States $0.091B 0.00
Aridis Pharmaceuticals (ARDS) United States $0.090B 0.00
Trevena (TRVN) United States $0.089B 0.00
Brainstorm Cell Therapeutics (BCLI) United States $0.087B 0.00
Catabasis Pharmaceuticals (CATB) United States $0.086B 0.00
Selecta Biosciences (SELB) United States $0.086B 0.00
Pluristem Therapeutics (PSTI) Israel $0.085B 0.00
InflaRx (IFRX) Germany $0.079B 0.00
Cohbar (CWBR) United States $0.079B 0.00
Verona Pharma American Depositary Share (VRNA) United Kingdom $0.077B 0.00
Merrimack Pharmaceuticals (MACK) United States $0.077B 0.00
Idera Pharmaceuticals (IDRA) United States $0.075B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.074B 0.00
Signal Genetics (MGEN) United States $0.072B 0.00
OVID THERAPEUTC (OVID) United States $0.070B 0.00
Unum Therapeutics (UMRX) United States $0.070B 0.00
Applied Genetic Technologies (AGTC) United States $0.068B 37.50
VTv Therapeutics (VTVT) United States $0.068B 0.00
ARAVIVE, INC (ARAV) United States $0.068B 0.00
Protalix BioTherapeutics (PLX) Israel $0.068B 0.00
Spring Bank Pharmaceuticals (SBPH) United States $0.067B 0.00
Orgenesis (ORGS) United States $0.067B 0.00
AquaBounty Technologies (AQB) United States $0.066B 0.00
Cocrystal Pharma (COCP) United States $0.065B 69.00
Alimera Sciences (ALIM) United States $0.065B 0.00
Prima BioMed (IMMP) Australia $0.062B 0.00
NewLink Genetics (NLNK) United States $0.058B 0.00
DiaMedica Therapeutics (DMAC) United States $0.058B 0.00
Vaccinex (VCNX) United States $0.058B 0.00
Curis (CRIS) United States $0.056B 0.00
Zosano Pharma (ZSAN) United States $0.055B 0.00
ScPharmaceuticals (SCPH) United States $0.055B 0.00
Hoth Therapeutics (HOTH) United States $0.054B 0.00
Moleculin Biotech (MBRX) United States $0.054B 0.00
Oncobiologics (OTLK) United States $0.053B 0.00
Ophthotech (ISEE) United States $0.052B 0.00
Proteostasis Therapeutics (PTI) United States $0.052B 0.00
Eyenovia (EYEN) United States $0.052B 0.00
Organovo Holdings (ONVO) United States $0.050B 0.00
Apricus Biosciences (SEEL) United States $0.049B 0.00
Sunesis Pharmaceuticals (SNSS) United States $0.046B 0.00
Bellerophon Therapeutics (BLPH) United States $0.045B 0.00
AEterna Zentaris (AEZS) United States $0.044B 0.00
Vascular Biogenics (VBLT) Israel $0.043B 0.00
Cidara Therapeutics (CDTX) United States $0.043B 0.00
Aptevo Therapeutics (APVO) United States $0.040B 0.00
Evogene (EVGN) Israel $0.039B 0.00
Clearside Biomedical (CLSD) United States $0.039B 0.00
Leap Therapeutics (LPTX) United States $0.038B 0.00
INNOVATE BIOPHARMACEUTICALS, INC (INNT) United States $0.038B 0.00
BiondVax Pharmaceuticals (BVXV) Israel $0.038B 0.00
Entera Bio (ENTX) Israel $0.037B 0.00
VIVUS (VVUS) United States $0.037B 0.00
Celsion (CLSN) United States $0.036B 0.00
AZURRX BIOPHARM (AZRX) United States $0.036B 0.00
Aerpio Pharmaceuticals (ARPO) United States $0.036B 0.00
Oncolytics Biotech (ONCY) Canada $0.035B 0.00
Celldex Therapeutics (CLDX) United States $0.035B 0.00
Akari Therapeutics (AKTX) United Kingdom $0.033B 0.00
Sienna Biopharmaceuticals (SNNA) United States $0.032B 0.00
Anchiano Therapeutics Sponsored ADR (ANCN) Israel $0.032B 0.00
Aytu Bioscience (AYTU) United States $0.030B 0.00
VistaGen Therapeutics (VTGN) United States $0.030B 0.00
Edge Therapeutics (PDSB) United States $0.030B 0.00
Bison Capital Acquisition (XYN) China $0.029B 0.00
Bionano Genomics (BNGO) United States $0.027B 0.00
Caladrius Biosciences (CLBS) United States $0.026B 0.00
Oragenics (OGEN) United States $0.025B 0.00
Sophiris Bio (SPHS) United States $0.023B 0.00
TRACON Pharmaceuticals (TCON) United States $0.023B 0.00
Rexahn Pharmaceuticals (REXN) United States $0.023B 0.00
Titan Pharmaceuticals (TTNP) United States $0.019B 0.00
Vical (VICL) United States $0.019B 0.00
Adial Pharmaceuticals (ADIL) United States $0.019B 0.00
Cleveland BioLabs (CBLI) United States $0.019B 0.00
GENPREX INC (GNPX) United States $0.019B 0.00
Fibrocell Science Inc (FCSC) United States $0.019B 0.00
Histogenics (HSGX) United States $0.019B 0.00
Pulmatrix (PULM) United States $0.017B 0.00
ATyr Pharma (LIFE) United States $0.017B 0.00
Gemphire Therapeutics (GEMP) United States $0.017B 0.00
OncoSec Medical (ONCS) United States $0.017B 0.00
Novelion Therapeutics (NVLN) Canada $0.016B 0.00
MYOS RENS Technology (MYOS) United States $0.015B 0.00
IBio (IBIO) United States $0.014B 0.00
Vital Therapies (IMUX) United States $0.014B 0.00
Novogen (KZIA) Australia $0.012B 0.00
Soligenix (SNGX) United States $0.012B 0.00
TrovaGene (TROV) United States $0.012B 0.00
Advaxis (ADXS) United States $0.012B 0.00
Prana Biotechnology (ATHE) Australia $0.011B 0.00
Aileron Therapeutics (ALRN) United States $0.011B 0.00
IMMURON LTD (IMRN) Australia $0.011B 0.00
Motif Bio Plc (MTFB) United States $0.011B 0.00
Genetic Technologies (GENE) Australia $0.010B 0.00
RestorGenex (DFFN) United States $0.010B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.009B 0.00
Flex Pharma (FLKS) United States $0.009B 0.00
Dare Bioscience (DARE) United States $0.009B 0.00
Synthetic Biologics (SYN) United States $0.009B 0.00
Therapix Biosciences (TRPX) Israel $0.009B 0.00
AmpliPhi Biosciences (ARMP) United States $0.009B 0.00
Hemispherx BioPharma (HEB) United States $0.008B 0.00
Proteon Therapeutics (PRTO) United States $0.008B 0.00
ARCA Biopharma (ABIO) United States $0.008B 0.00
Tenax Therapeutics (TENX) United States $0.008B 0.00
Benitec Biopharma (BNTC) Australia $0.008B 0.00
BioPharmX (BPMX) United States $0.007B 0.00
Stellar Biotechnologies (EDSA) United States $0.006B 0.00
Neuralstem (CUR) United States $0.006B 0.00
Cytori Therapeutics Inc (CYTX) United States $0.005B 0.00
ContraVir Pharmaceuticals Inc (CTRV) United States $0.004B 0.00
Galena Biopharma (SLS) United States $0.003B 0.00
Cellect Biotechnology (APOP) Israel $0.003B 0.00
Bio-Rad Laboratories (BIO.B) United States $0.000B 0.00
Horizon Pharma Public (HZNP) Ireland $0.000B 0.00
MEREO BIOPHARMA (MREO) United Kingdom $0.000B 0.00